Beam Therapeutics Inc. company logo
Beam Therapeutics Inc. logo

Beam Therapeutics Inc. (BEAM) Cash and Cash Equivalents

Annual Cash & Cash Equivalents

$281.97M$153.93M-35.31%

Summary

Current Value
As of today, BEAM annual cash & cash equivalents is $281.97M, down -35.31% on
Historical Performance
BEAM annual cash & cash equivalents is down -49.65% over the past 3 years, and up +657.55% over the past 5 years
All-Time High Comparison
BEAM annual cash & cash equivalents is currently -49.65% below its historical high of $559.99M set on
3-Year Low Comparison
BEAM annual cash & cash equivalents is +21.14% above its 3-year low of $232.77M reached on an earlier date
Sector Comparison
BEAM annual cash & cash equivalents is higher than 82.91% of companies in Healthcare sector

Cash and Cash Equivalents Chart

Add series to chart
Add series to chart1/6
Series
SUGGESTED SERIES

Performance

BEAM Performance
MetricDateValue1Y3Y5Y15Y
Annual Cash & Cash Equivalents$281.97M-35.3%-49.6%+657.5%+10000.0%
Quarterly Cash & Cash Equivalents$1.07B+16.1%-1.8%+431.6%
Price$31.56+20.1%-28.9%-68.3%
Annual Current Assets$878.15M-27.5%-31.0%+828.8%+10000.0%
Annual Total Liabilities$370.28M-22.6%-42.8%+571.4%+5523.1%
Annual Working Capital$696.08M-30.8%-34.3%+964.3%+10000.0%
Annual Net Income-$376.74M-184.3%-1.6%-381.0%-4608.1%

Cash and Cash Equivalents Highs

BEAM Annual Cash & Cash Equivalents Highs Comparison
PeriodHighDateCurrent
3Y$435.90M-35.3%
5Y$559.99M-49.6%
All$559.99M-49.6%

Cash and Cash Equivalents Lows

BEAM Annual Cash & Cash Equivalents Lows Comparison
PeriodLowDateCurrent
3Y$232.77MN/A+21.1%
5Y$162.17MN/A+73.9%
All$1.90M>+9999.0%

Cash and Cash Equivalents History

YearValueChange
$281.97M-35.3%
$435.90M+87.3%
$232.77M-58.4%
$559.99M+245.3%
YearValueChange
$162.17M+335.7%
$37.22M-74.6%
$146.44M+7,603.5%
$1.90M-

FAQ

  • What is the current annual cash & cash equivalents of BEAM?

    As of today, BEAM annual cash & cash equivalents is $281.97M

  • What is 1-year change in BEAM annual cash & cash equivalents?

    BEAM annual cash & cash equivalents is down -35.31% year-over-year

  • What is 3-year change in BEAM annual cash & cash equivalents?

    BEAM annual cash & cash equivalents is down -49.65% over the past 3 years

  • How far is BEAM annual cash & cash equivalents from its all-time high?

    BEAM annual cash & cash equivalents is currently -49.65% below its historical high of $559.99M set on December 31, 2021

  • How does BEAM annual cash & cash equivalents rank versus sector peers?

    BEAM annual cash & cash equivalents is higher than 82.91% of companies in Healthcare sector

  • When is BEAM next annual earnings release?

    The next annual earnings release for BEAM is on

Cash and Cash Equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

Data Sources & References

  1. BEAM Official Website beamtx.com
  2. Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1745999/000119312525263542/0001193125-25-263542-index.htm
  3. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1745999/000095017025026076/0000950170-25-026076-index.htm
  4. BEAM Profile on Yahoo Finance finance.yahoo.com/quote/BEAM
  5. BEAM Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/beam